Back to Authors

Royston, Minying

0000-0002-4251-5104

A5109534973 | I4210125492

Mayo Clinic

Alexion Pharmaceuticals (United States)

Citations 1

Indirect Comparison Analysis of FDA-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder (P15-1.007)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.1618